JANX
Janux Therapeutics Inc
NASDAQ: JANX · HEALTHCARE · BIOTECHNOLOGY
$14.37
+1.84% today
Updated 2026-04-30
Market cap
$882.06M
P/E ratio
—
P/S ratio
88.21x
EPS (TTM)
$-1.83
Dividend yield
—
52W range
$12 – $35
Volume
1.0M
Janux Therapeutics Inc (JANX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $679000.00 | $16.22M | $379.82M | $364.01M | $380.41M | $1.06B |
| Cash & equivalents | $658000.00 | $7.81M | $35.58M | $51.43M | $19.20M | $430.61M |
| Current assets | $658000.00 | $16.06M | $377.02M | $332.44M | $349.24M | $1.03B |
| Total liabilities | $8.62M | $30.86M | $13.50M | $43.27M | $36.06M | $38.73M |
| Current liabilities | $4.63M | $3.18M | $12.80M | $16.51M | $13.03M | $17.46M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-7.94M | $-14.64M | $366.33M | $320.74M | $344.35M | $1.02B |
| Retained earnings | $-7.96M | $-14.74M | $-47.41M | $-110.47M | $-168.76M | $-237.76M |
| Accounts receivable | $0.00 | $8.00M | $200000.00 | $700000.00 | $2.20M | $5.38M |
| Inventory | — | — | $-200000.00 | $-700000.00 | $-2.20M | — |
| Goodwill | — | — | — | — | — | — |